Nationwide registry-based analysis of cardiovascular risk factors and adverse outcomes in patients treated with strontium ranelate.
about
Managing osteoarthritisManaging Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral ResearchRapid phenotyping of knockout mice to identify genetic determinants of bone strengthEfficacy of Osteoporosis Therapies in Diabetic Patients.Injectable hybrid system for strontium local delivery promotes bone regeneration in a rat critical-sized defect model.Cardiac concerns associated with strontium ranelateNew strategies for osteoporosis patients previously managed with strontium ranelate.Osteoporosis in men: a review.History of cardiovascular events and cardiovascular risk factors among patients initiating strontium ranelate for treatment of osteoporosisItalian association of clinical endocrinologists (AME) position statement: drug therapy of osteoporosis.The position of strontium ranelate in today's management of osteoporosis.Presentation and management of osteoporosis presenting in association with pregnancy or lactation.Treatment of osteoporosis after alendronate or risedronate.In vivo and clinical application of strontium-enriched biomaterials for bone regeneration: A systematic review.Harnessing the bone-seeking ability of Ca(II)-like metal ions in the treatment of metastatic cancer and resorption disorders.Cardiovascular safety of strontium ranelate: real-life assessment in clinical practice.Use of strontium ranelate and risk of acute coronary syndrome: cohort study.A Review on Bone Mineral Density Loss in Total Knee Replacements Leading to Increased Fracture Risk.Low-dose strontium stimulates osteogenesis but high-dose doses cause apoptosis in human adipose-derived stem cells via regulation of the ERK1/2 signaling pathway.Effects of strontium ranelate on markers of cardiovascular risk in postmenopausal osteoporotic women.Strontium ranelate promotes odonto-/osteogenic differentiation/mineralization of dental papillae cells in vitro and mineralized tissue formation of the dental pulp in vivo.
P2860
Q26773279-97241FB8-47BA-4F87-A62C-D51B98A6505CQ26782621-ADFAD103-B3D3-4E73-B462-D61FC4B3B392Q28066355-9BDA33B7-D2AD-4C48-A180-B5B152830F2AQ30248776-62553F81-0E2B-4857-A410-DBE455FF9827Q33895089-CC7635F5-6116-4193-AB62-DD487780245AQ34336113-20B73A43-A1DF-4B39-9242-7863C22DB538Q34550435-5001D377-A7F9-4329-9A40-0455D22C52D8Q35755160-D5693E6B-BA8A-4B8B-AD13-65DB166A8D27Q36307235-E364D6DF-1A3F-4FE9-90E1-6514C8079934Q37135281-68F82222-6662-46CE-B9F8-2F5B4EB73451Q38418620-B8824DA6-1010-4B2E-BA20-2D85AA62BF06Q38457933-29BA7972-5595-40F4-B1B2-665DBD9528F7Q38599682-43E4F7B8-F7AA-40EE-9949-DDF12F7DCC7CQ38672632-FA77A3B8-8F23-4782-A28A-A6266499425CQ38725565-7BDFFBCD-0BF2-4C05-9C8D-924381664CCBQ42723026-F095F3AA-AE99-43F1-8BEC-0FA419B7A584Q43867034-2B08BB33-3923-4D56-A87B-6F141C1BD1DAQ46027277-F8614D86-5C09-4F8D-AAF9-49ADB0D518D5Q47239513-B7327D22-0FEA-4652-A112-893EC6FFDB4EQ51298130-BFDF693A-2684-4EFB-B8F7-DB43EFD1BAE1Q55357818-C6C22509-4574-4224-BC38-EB122FC2546E
P2860
Nationwide registry-based analysis of cardiovascular risk factors and adverse outcomes in patients treated with strontium ranelate.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Nationwide registry-based anal ...... eated with strontium ranelate.
@en
Nationwide registry-based anal ...... eated with strontium ranelate.
@nl
type
label
Nationwide registry-based anal ...... eated with strontium ranelate.
@en
Nationwide registry-based anal ...... eated with strontium ranelate.
@nl
prefLabel
Nationwide registry-based anal ...... eated with strontium ranelate.
@en
Nationwide registry-based anal ...... eated with strontium ranelate.
@nl
P2860
P1476
Nationwide registry-based anal ...... eated with strontium ranelate.
@en
P2093
P Vestergaard
P2860
P2888
P304
P356
10.1007/S00198-013-2469-4
P407
P577
2013-08-14T00:00:00Z